Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.
All articles by Victoria Forster, PhD
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Women in academic medicine typically have lower starting salaries than men, and this disparity remains after 10 years on the job.
Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.
Phase 2 clinical trial shows promising result for dabrafenib and trametinib combination in patients with advanced cholangiocarcinoma with a BRAFV600E mutation.
Research presented at SITC 2019 looks at 2 different mechanisms for resistance to immune checkpoint inhibition in pancreatic ductal adenocarcinoma.
Pexa-Vec, in combination with sorafenib, has failed an interim futility analysis, leading to the early termination of the trial.